Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer

This research found that the clinical outcomes (PFS, ORR, OS) of the non-platinum-based doublet regimen (docetaxel capecitabine combination) were similar to those of the platinum-based (oxaliplatin capecitabine combination) when used as first line therapy for MGC patients.BackgroundDocetaxel, platin...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Xiao-Yin Zhao, Xin Liu, Wen-Hua Li, Li-Xin Qiu, Ming-Zhu Huang, Chen-Chen Wang, Zhi-Yu Chen, Wen Zhang, Wan-Jing Feng, Wei-Jian Guo, Xiaodong Zhu
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2022-10-01
Serier:	Frontiers in Oncology
Fag:	Stomach neoplasm (gastric cancer) chemotherapy docetaxel (DOC) capecitabine oxaliplatin (L-OHP)
Online adgang:	https://www.frontiersin.org/articles/10.3389/fonc.2022.911160/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!